Related references
Note: Only part of the references are listed.Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression
Rene Nieves-Alicea et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters
Andrea Ventura et al.
CELL (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism
Shuji Fujita et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
Lisa B. Frankel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Altered microRNA expression confined to specific epithelial cell Subpopulations in breast cancer
Lorenzo F. Sempere et al.
CANCER RESEARCH (2007)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Gam1-associated alterations of drug responsiveness through activation of apoptosis
Fangting Wu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A trimeric anti-HER2/neu ScFv and tumor necrosis factor-α fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia
TH Huang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
miRBase: microRNA sequences, targets and gene nomenclature
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2006)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Phylogenetic shadowing and computational identification of human microRNA genes
E Berezikov et al.
CELL (2005)
Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression
I Carvalho et al.
BREAST CANCER RESEARCH (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
HER2 expression in cervical cancer as a potential therapeutic target -: art. no. 59
A Chavez-Blanco et al.
BMC CANCER (2004)
Cre-lox-regulated conditional RNA interference from transgenes
A Ventura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
YM Li et al.
CANCER CELL (2004)
A custom microarray platform for analysis of microRNA gene expression
JM Thomson et al.
NATURE METHODS (2004)
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
S Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA
M Böhm et al.
ONCOGENE (2003)
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
KSM Smalley
INTERNATIONAL JOURNAL OF CANCER (2003)
Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth
MT Ling et al.
ONCOGENE (2002)
Regulation of Raf-Akt cross-talk
K Moelling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - Evidence for involvement of AP-1 and PEA3
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway
R Paumelle et al.
ONCOGENE (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1
DG Bosc et al.
ONCOGENE (2001)
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
DH Yu et al.
ONCOGENE (2000)
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
EJ Filardo et al.
MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
